← Open Payments lookup

DAVID DRANEY: Open Payments

NPI 1891141644 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,845 in 99 payments from 13 companies in 2025. Trend: 2023 $1,605 · 2024 $1,987 · 2025 $1,845

Food & beverage: $1,765Education: $80
CompanyPaymentsAmount
ABBVIE INC.35$596
Otsuka America Pharmaceutical, Inc.12$215
Neurocrine BioSciences, Inc.9$196
Teva Pharmaceuticals USA, Inc.9$192
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$147
Janssen Pharmaceuticals, Inc7$124
Lundbeck LLC7$113
Supernus Pharmaceuticals, Inc.3$81
Axsome Therapeutics, Inc.3$59
E.R. Squibb & Sons, L.L.C.2$43

Products named: VRAYLAR, REXULTI, INGREZZA, CAPLYTA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, Qelbree, UZEDY.

Industry payments across AR — which companies pay providers there.